BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24318095)

  • 1. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome.
    Yopp AC; Mansour JC; Beg MS; Arenas J; Trimmer C; Reddick M; Pedrosa I; Khatri G; Yakoo T; Meyer JJ; Shaw J; Marrero JA; Singal AG
    Ann Surg Oncol; 2014 Apr; 21(4):1287-95. PubMed ID: 24318095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan: A multicenter collaborative observational study.
    Murai K; Hikita H; Kodama T; Kaibori M; Nishimura Y; Tatsumi T; Yamada T; Kanto T; Mochida S; Takehara T
    Hepatol Res; 2024 May; 54(5):439-450. PubMed ID: 37983632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival.
    Agarwal PD; Phillips P; Hillman L; Lucey MR; Lee F; Mezrich JD; Said A
    J Clin Gastroenterol; 2017 Oct; 51(9):845-849. PubMed ID: 28877082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
    Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
    Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives.
    Oh JH; Sinn DH
    J Liver Cancer; 2024 Mar; 24(1):47-56. PubMed ID: 38527905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape.
    Kinsey E; Lee HM
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of multidisciplinary team care on patient survival in chronic hepatitis B or C hepatocellular carcinoma.
    Tseng YC; Kung PT; Peng CY; Chou WY; Tsai WC
    Front Oncol; 2023; 13():1251571. PubMed ID: 38179172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HiCCups in management-Pitfalls and pearls for the management of HCC.
    Aby ES; Pillai A
    Clin Liver Dis (Hoboken); 2023 Sep; 22(3):85-88. PubMed ID: 37799639
    [No Abstract]   [Full Text] [Related]  

  • 9. Concordance of a decision algorithm and multidisciplinary team meetings for patients with liver cancer-a study protocol for a randomized controlled trial.
    Ng SST; Oehring R; Ramasetti N; Roller R; Thomas P; Chen Y; Moosburner S; Winter A; Maurer MM; Auer TA; Kamali C; Pratschke J; Benzing C; Krenzien F
    Trials; 2023 Sep; 24(1):577. PubMed ID: 37684688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Kulkarni AV; Tevethia H; Kumar K; Premkumar M; Muttaiah MD; Hiraoka A; Hatanaka T; Tada T; Kumada T; Kakizaki S; Vogel A; Finn RS; Rao PN; Pillai A; Reddy DN; Singal AG
    EClinicalMedicine; 2023 Sep; 63():102179. PubMed ID: 37680945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Establishing a Dedicated Liver Surgery Program at a University-affiliated Hospital on Workforce, Workload, Surgical Outcomes, and Trainee Surgical Autonomy and Academic Output.
    Azoulay D; Eshkenazy R; Pery R; Cordoba M; Haviv Y; Inbar Y; Zisman E; Lahat E; Salloum C; Lim C
    Ann Surg Open; 2021 Jun; 2(2):e066. PubMed ID: 37636559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological Diagnosis of Chronic Liver Disease and Hepatocellular Carcinoma: A Review.
    Singh S; Hoque S; Zekry A; Sowmya A
    J Med Syst; 2023 Jul; 47(1):73. PubMed ID: 37432493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hospital volume and operative mortality in hepato-biliary surgery in Veneto region, Italy.
    Guglielmi A; Tripepi M; Salmaso L; Fedeli U; Ruzzenente A; Saia M
    Updates Surg; 2023 Oct; 75(7):1949-1959. PubMed ID: 37395932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease-related hepatocellular carcinoma.
    Daher D; Dahan KSE; Singal AG
    J Liver Cancer; 2023 Mar; 23(1):127-142. PubMed ID: 37384032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
    Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
    J Liver Cancer; 2023 Mar; 23(1):1-120. PubMed ID: 37384024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma.
    Cao Y; Mezzacappa C; Jaffe A; Strazzabosco M; Taddei TH
    J Multidiscip Healthc; 2023; 16():1531-1540. PubMed ID: 37283950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of interdisciplinarity in modern oncology: results of a national intergroup survey of the Young Oncologists United (YOU).
    Mäurer M; Staudacher J; Meyer R; Mäurer I; Lazaridis L; Müther M; Huber T; Sommer NP; Fleischmann DF; Käsmann L; Ziegler S; Kropf-Sanchen C; Wikert J; Pietzner K; Holzgreve A; Nestler T; Siech C; Sturm MJ; Sulzer S; Heinrich K; Stahler A;
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10075-10084. PubMed ID: 37261525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Multidisciplinary Tumor Board Discussions Correlate With Increase in 5-Year Survival? A Meta-Analysis Study.
    Algwaiz G; Salam Y; Bustami R; Ferwana M; Jazieh AR
    Glob J Qual Saf Healthc; 2021 Feb; 4(1):3-10. PubMed ID: 37260532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
    Singal AG; Llovet JM; Yarchoan M; Mehta N; Heimbach JK; Dawson LA; Jou JH; Kulik LM; Agopian VG; Marrero JA; Mendiratta-Lala M; Brown DB; Rilling WS; Goyal L; Wei AC; Taddei TH
    Hepatology; 2023 Dec; 78(6):1922-1965. PubMed ID: 37199193
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment.
    Cox DRA; Chung W; Grace J; Wong D; Kutaiba N; Ranatunga D; Khor R; Perini MV; Fink M; Jones R; Goodwin M; Dobrovic A; Testro A; Muralidharan V
    JGH Open; 2023 Apr; 7(4):249-260. PubMed ID: 37125252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.